1. 19PPreclinical drug testing and clinical trial planning of palbociclib (CDK4/6 inhibitor) drug combination with a PI3K or MAPK inhibitor for colorectal cancer (CRC). (27th February 2019) Authors: Lee, C L; Toomey, S; Farrelly, A; Hennessy, B Journal: Annals of oncology Issue: Volume 30(2019)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 138PMonitoring the effect of PI3K inhibition on HER2 therapy resistant breast cancer using serial analysis of PIK3CA mutant tumour DNA in plasma. (23rd October 2018) Authors: Keegan, N; Toomey, S; Farrelly, A; Carr, A; Calzaferri, G; Walshe, J; Gullo, G; Crown, J P; Egan, K; Hernando, A; Teiserskiene, A; Grogan, L; Breathnach, O S; Morris, P G; Hennessy, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 551PNon-invasive genotyping and monitoring of tumor evolution in locally advanced rectal cancer (LARC) patients using circulating tumor DNA (ctDNA). (23rd October 2018) Authors: Toomey, S; Sartori, A; Irwin, D; Hummel, S; Carr, A; Lee, C L; Armstrong, P; Farrelly, A; El-Masry, S; McNamara, D; Morris, P G; Grogan, L; Breathnach, O S; O'Sullivan, L; Bradshaw, S; Rashed, A N A M; Smyth, R; Workman, J; O'Neill, B; Hennessy, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 126 A 10 year clinico-pathological study of residual/recurrent borderline ovarian tumours in young females undergoing fertility-preserving surgery. (13th November 2020) Authors: Toomey, S; Basha Mohamed, M; Arora, R Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗